489 related articles for article (PubMed ID: 30476497)
21. Colonoscopy-based colorectal cancer modeling in mice with CRISPR-Cas9 genome editing and organoid transplantation.
Roper J; Tammela T; Akkad A; Almeqdadi M; Santos SB; Jacks T; Yilmaz ÖH
Nat Protoc; 2018 Feb; 13(2):217-234. PubMed ID: 29300388
[TBL] [Abstract][Full Text] [Related]
22. Gastrointestinal cancer organoids-applications in basic and translational cancer research.
Seidlitz T; Stange DE
Exp Mol Med; 2021 Oct; 53(10):1459-1470. PubMed ID: 34663939
[TBL] [Abstract][Full Text] [Related]
23. Generation of gene-of-interest knockouts in murine organoids using CRISPR-Cas9.
Huber A; Dijkstra C; Ernst M; Eissmann MF
STAR Protoc; 2023 Mar; 4(1):102076. PubMed ID: 36853714
[TBL] [Abstract][Full Text] [Related]
24. Gene Editing and Human Pluripotent Stem Cells: Tools for Advancing Diabetes Disease Modeling and Beta-Cell Development.
Millette K; Georgia S
Curr Diab Rep; 2017 Oct; 17(11):116. PubMed ID: 28980194
[TBL] [Abstract][Full Text] [Related]
25. CRISPR Manipulations in Stem Cell Lines.
Chang YJ; Cui X; Levi SR; Jenny LA; Tsang SH
Methods Mol Biol; 2023; 2560():249-256. PubMed ID: 36481901
[TBL] [Abstract][Full Text] [Related]
26. Organoid based personalized medicine: from bench to bedside.
Li Y; Tang P; Cai S; Peng J; Hua G
Cell Regen; 2020 Nov; 9(1):21. PubMed ID: 33135109
[TBL] [Abstract][Full Text] [Related]
27. Modeling Down syndrome in cells: From stem cells to organoids.
Gough G; O'Brien NL; Alic I; Goh PA; Yeap YJ; Groet J; Nizetic D; Murray A
Prog Brain Res; 2020; 251():55-90. PubMed ID: 32057312
[TBL] [Abstract][Full Text] [Related]
28. Intestinal organoids as tissue surrogates for toxicological and pharmacological studies.
Kuratnik A; Giardina C
Biochem Pharmacol; 2013 Jun; 85(12):1721-6. PubMed ID: 23623789
[TBL] [Abstract][Full Text] [Related]
29. Housekeeping gene variability in normal and cancerous colorectal, pancreatic, esophageal, gastric and hepatic tissues.
Rubie C; Kempf K; Hans J; Su T; Tilton B; Georg T; Brittner B; Ludwig B; Schilling M
Mol Cell Probes; 2005 Apr; 19(2):101-9. PubMed ID: 15680211
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
[TBL] [Abstract][Full Text] [Related]
31. Expression analysis of MAC30 in human pancreatic cancer and tumors of the gastrointestinal tract.
Kayed H; Kleeff J; Ding J; Hammer J; Giese T; Zentgraf H; Büchler MW; Friess H
Histol Histopathol; 2004 Oct; 19(4):1021-31. PubMed ID: 15375745
[TBL] [Abstract][Full Text] [Related]
32. Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer.
Vorvis C; Hatziapostolou M; Mahurkar-Joshi S; Koutsioumpa M; Williams J; Donahue TR; Poultsides GA; Eibl G; Iliopoulos D
Am J Physiol Gastrointest Liver Physiol; 2016 Jun; 310(11):G1124-37. PubMed ID: 27151939
[TBL] [Abstract][Full Text] [Related]
33. CRISPR therapeutic tools for complex genetic disorders and cancer (Review).
Baliou S; Adamaki M; Kyriakopoulos AM; Spandidos DA; Panayiotidis M; Christodoulou I; Zoumpourlis V
Int J Oncol; 2018 Aug; 53(2):443-468. PubMed ID: 29901119
[TBL] [Abstract][Full Text] [Related]
34. Biomarkers in gastroenterology: between hope and hype comes histopathology.
Jankowski JA; Odze RD
Am J Gastroenterol; 2009 May; 104(5):1093-6. PubMed ID: 19417749
[TBL] [Abstract][Full Text] [Related]
35. Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease.
Corfield AP; Myerscough N; Longman R; Sylvester P; Arul S; Pignatelli M
Gut; 2000 Oct; 47(4):589-94. PubMed ID: 10986224
[No Abstract] [Full Text] [Related]
36. CRISPR/Cas9 system as an innovative genetic engineering tool: Enhancements in sequence specificity and delivery methods.
Jo YI; Suresh B; Kim H; Ramakrishna S
Biochim Biophys Acta; 2015 Dec; 1856(2):234-43. PubMed ID: 26434948
[TBL] [Abstract][Full Text] [Related]
37. Modeling infectious diseases and host-microbe interactions in gastrointestinal organoids.
Bartfeld S
Dev Biol; 2016 Dec; 420(2):262-270. PubMed ID: 27640087
[TBL] [Abstract][Full Text] [Related]
38. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
Zhang Y; Sastre D; Wang F
Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
[TBL] [Abstract][Full Text] [Related]
39. Application of CRISPR-Cas9 in eye disease.
Wu W; Tang L; D'Amore PA; Lei H
Exp Eye Res; 2017 Aug; 161():116-123. PubMed ID: 28619505
[TBL] [Abstract][Full Text] [Related]
40. CRISPR/Cas9 Screen in Gastric Cancer Patient-Derived Organoids Reveals KDM1A-NDRG1 Axis as a Targetable Vulnerability.
Mircetic J; Camgöz A; Abohawya M; Ding L; Dietzel J; Tobar SG; Paszkowski-Rogacz M; Seidlitz T; Schmäche T; Mehnert MC; Sidorova O; Weitz J; Buchholz F; Stange DE
Small Methods; 2023 Jun; 7(6):e2201605. PubMed ID: 36908010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
